Amifostine trihydrate CAS:112901-68-5
Description:White crystalline powder
Assay: NLT99.5%(Including crystal water)
Product Name: Amifostine trihydrate; Amifostine 3H2O; WR2721; WR-2721; Ethyol;Ethiophos; Gammaphos; SAPEP
CAS No.: 112901-68-5
Synonyms: 2-(3-Aminopropylamino)ethylsulfanylphosphonic acid trihydrate; 2-(3-Aminopropyl)aminoethyl phosphorothioate;1-(dihydrogen phosphate) 2-[(3-aminopropyl)amino]-ethanethiol, trihydrate
Molecular Formula: C5H21N2O6PS; C5H15N2O3PS.3H2O
Molecular weight: 268.27
Application: Amifostine may provide renal protection during PRRT using somatostatin analogs by mitigating radiation damage and reducing the absorbed kidney radiation dose. Amifostine remediates the degenerative effects of radiation on the mineralization capacity of the murine mandible. Radioprotective agent. Selectively protects normal tissues from the damaging effects of anti-neoplastic radiation therapy. Selectivity is due to preferential uptake by normal tissues and subsequent metabolic activation to 2-(3-aminopropyl)aminoethanethiol.
Amifostine is a prodrug that through dephosphorylation by alkaline phosphatase is converted to an active thiol, WR 1065 that has free radical scavenging, DNA protective, and hypoxia inducing activities. Because of the differential expression of alkaline phosphatase in normal versus neoplastic tissues, the cytoprotection conferred by amifostine is selective, enabling as much as 100-fold greater accumulation of WR 1065 in normal tissues than in tumor cells.Amifostine has been used to reduce toxicity in normal tissues exposed to radiation or chemotherapeutic agents.In mouse fibroblasts and various cancer cells, amifostine (IC50 ~4 mM) has been shown to activate p53 protein, to induce the expression of the cyclin-dependent kinase inhibitor p21, and to arrest cells at the G1/S transition through a p53-dependent mechanism. Amifostine is a chemopreventive drug used to selectively protect normal tissues from the side effects of chemotherapy drugs such as cyclophosphmide, mitomucin-C and cisplatin, and ionising radiation therapy. Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
關(guān)鍵字： Amifostine trihydrate
凱立德生物醫(yī)藥是一家專門從事化學(xué)定制合成，醫(yī)藥中間體以及新藥研發(fā)的外向型企業(yè)。公司堅(jiān)持以科技創(chuàng)新為動(dòng)力，以市場(chǎng)需求為導(dǎo)向，產(chǎn)品涵蓋醫(yī)藥原料，醫(yī)藥中間體，天然產(chǎn)物,手性化合物，藥物研究試劑等。同時(shí)致力于為國(guó)內(nèi)外知名藥企，科研機(jī)構(gòu)及高校提供新型和高附加值的醫(yī)藥原料、醫(yī)藥中間體及天然產(chǎn)物的訂制合成服務(wù)。
公司自成立以來，始終堅(jiān)持客戶至上的經(jīng)營(yíng)理念，不斷進(jìn)取，贏得了國(guó)內(nèi)外客戶的好評(píng)與信任，并與其建立了長(zhǎng)期穩(wěn)定的業(yè)務(wù)關(guān)系。公司將一如既往的以嚴(yán)格的質(zhì)量管理體系，穩(wěn)定的產(chǎn)品質(zhì)量為客戶提供優(yōu)質(zhì)的產(chǎn)品和服務(wù)。
ChemLeader Biomedical is a professional manufacturer and supplier of New Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API) & Drug Impurities.
ChemLeader mainly manufactures & supplies pharmaceutical Intermediates, API & Drug Impurities, Nutri-Health Supplements, and Cosmetic Ingredients.